Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Edelweiss Recently Listed IPO Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseEdelweissHDFC
NAV₹33.4822₹22.8170
NAV date20 Nov 202620 Nov 2026
History8.7 years3.1 years
Expense ratio2.7%2.1%
Stars★★★★★★★★★★
Growth Score44.7093.90

Returns

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
1 month+5.80%+12.87%
3 months+2.08%+6.85%
6 months+19.60%+17.20%
YTD+23.82%+32.43%
1 year+22.21%+30.73%
3 years (CAGR)+15.66%+29.16%
5 years (CAGR)+9.59%—
10 years (CAGR)——
Since launch+14.82%+30.28%

Risk

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Volatility20.9%15.8%
Downside volatility13.1%8.6%
Sharpe0.441.44
Sortino0.702.64
Calmar0.631.94
Return / risk0.751.85
Deepest fall−32.34%−15.07%
Days to recover155133
Below its high−1.65%+0.00%

Against benchmark

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Alpha+4.43%+6.36%
Beta0.970.97
R²56.3%85.0%
Up capture111.0%106.7%
Down capture96.2%74.4%
Tracking error13.8%6.1%
Information ratio0.310.97
Treynor0.090.22

Consistency

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
Best 1-year+97.69%+64.96%
Middle 1-year+16.18%+21.84%
Worst 1-year−24.34%+0.52%
1-year periods with a loss26.2%0.0%
Middle 3-year+17.58%+28.68%
Positive months66.7%69.4%
Best day+3.68%+3.19%
Worst day−5.79%−3.62%
Worst 5% day−1.94%−1.50%
Positive days57.4%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Edelweiss Recently Listed IPO FundHDFC Pharma and Healthcare Fund
5-year XIRR+16.40%—
5-year value₹9,11,471—
3-year XIRR+16.90%+26.26%
1-year XIRR+33.64%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth